RC

Rinaben Chetanbhai Rathod

Active Director Designated Partner DIN 10030835
DIN 10030835 First appointment Nov 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Rinaben Chetanbhai Rathod

Data last updated:

Rinaben Chetanbhai Rathod is a Designated Partner at Nandini Super Speciality Hospital Llp (since 2022). The company operates in Healthcare.

DIN 10030835
Primary Designation Designated Partner
Industry Healthcare
First Appointment 29 Nov 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Nov 20222022Active

Board colleagues of Rinaben Chetanbhai Rathod

Directorship timeline

Open interactive timeline →
Nandini Super Speciality Hospital Llp
Premium access

Shareholding and investment profile for Rinaben Chetanbhai Rathod

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rinaben Chetanbhai Rathod

Rinaben Chetanbhai Rathod currently holds 1 directorship: Nandini Super Speciality Hospital Llp (Designated Partner, since 29 Nov 2022).

Rinaben Chetanbhai Rathod was first appointed on 29 Nov 2022 as Designated Partner at Nandini Super Speciality Hospital Llp.

The current boards of Rinaben Chetanbhai Rathod's companies include Chetankumar Pravinbhai Rathod (Nandini Super Speciality Hospital Llp), Kalpeshkumar Pravinbhai Rathod (Nandini Super Speciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available